Literature DB >> 28610723

Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis.

Dennis H Lau1, Dominik Linz2, Ulrich Schotten3, Rajiv Mahajan4, Prashanthan Sanders4, Jonathan M Kalman5.   

Abstract

Recent advances in our understanding of the mechanisms underlying atrial fibrillation (AF) have further underscored the complex pathophysiological basis of the arrhythmia. It has become apparent that the current clinical classification of AF does not reflect the severity of the underlying atrial disease. Atrial fibrosis has been identified as the key structural change in different substrates that are responsible for the perpetuation of AF. Three-dimensional electroanatomical mapping and late gadolinium-enhanced magnetic resonance imaging are novel modalities that can be used to facilitate identification and quantitation of atrial fibrosis for improved delineation of the AF substrate. Advances in AF mapping technology using endocardial 'panaromic' basket-type catheter and non-invasive body surface electrodes have facilitated the identification of two major arrhythmic mechanisms of interest, namely rotational ('rotors') and ectopic focal activations ('foci'). Ongoing research on these potential drivers of AF may provide guidance to more mechanistic based therapies to improve outcomes for this complex arrhythmia in the future. Here, we aim to review the differences in AF substrate in those with paroxysmal and more persistent forms of the arrhythmia by evaluating fibrosis, rotors and foci, towards improved AF substrate classification and individualised substrate based therapies.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Atrial fibrillation; Atrial fibrosis; Ectopic foci; Mapping; Remodelling; Rotors

Mesh:

Year:  2017        PMID: 28610723     DOI: 10.1016/j.hlc.2017.05.119

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  36 in total

1.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

Review 2.  The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.

Authors:  Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz
Journal:  Clin Res Cardiol       Date:  2018-04-12       Impact factor: 5.460

3.  Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.

Authors:  João Mesquita; Diogo Cavaco; António Miguel Ferreira; Francisco Moscoso Costa; Pedro Carmo; Francisco Morgado; Miguel Mendes; Pedro Adragão
Journal:  J Interv Card Electrophysiol       Date:  2018-03-06       Impact factor: 1.900

4.  Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation.

Authors:  Adrian D Elliott; Rajiv Mahajan; Dominik Linz; Michael Stokes; Christian V Verdicchio; Melissa E Middeldorp; Andre La Gerche; Dennis H Lau; Prashanthan Sanders
Journal:  Clin Cardiol       Date:  2018-06-12       Impact factor: 2.882

Review 5.  The role of personalized atrial modeling in understanding atrial fibrillation mechanisms and improving treatment.

Authors:  Konstantinos N Aronis; Rheeda Ali; Natalia A Trayanova
Journal:  Int J Cardiol       Date:  2019-01-31       Impact factor: 4.164

Review 6.  The Association Between Atrial Fibrillation and Endurance Physical Activity: How Much is too Much?

Authors:  Osmar Antonio Centurión; José C Candia; Karina E Scavenius; Laura B García; Judith M Torales; Luís Marcelo Miño
Journal:  J Atr Fibrillation       Date:  2019-10-31

7.  MIAT, a potent CVD-promoting lncRNA.

Authors:  Chao Yang; Yong Zhang; Baofeng Yang
Journal:  Cell Mol Life Sci       Date:  2021-12-18       Impact factor: 9.261

8.  Preprocedure Application of Machine Learning and Mechanistic Simulations Predicts Likelihood of Paroxysmal Atrial Fibrillation Recurrence Following Pulmonary Vein Isolation.

Authors:  Julie K Shade; Rheeda L Ali; Dante Basile; Dan Popescu; Tauseef Akhtar; Joseph E Marine; David D Spragg; Hugh Calkins; Natalia A Trayanova
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-06-14

Review 9.  Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives.

Authors:  Francesco De Sensi; Diego Penela; David Soto-Iglesias; Antonio Berruezo; Ugo Limbruno
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

10.  Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Ruopeng Tan; Haixu Yu; Xu Han; Yang Liu; Xiaolei Yang; Yun-Long Xia; Xiaomeng Yin
Journal:  Front Cardiovasc Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.